There are 2949 resources available
596TiP - Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours
Presenter: John Powderly
Session: E-Poster Display
Resources:
Abstract
597TiP - A phase Ib study on a TRPV6-inhibitor, SORC13 in patients with advanced solid tumours
Presenter: Siqing Fu
Session: E-Poster Display
Resources:
Abstract
598TiP - A phase I/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumours
Presenter: Jason Luke
Session: E-Poster Display
Resources:
Abstract
599TiP - BT8009-100 phase I/II study of the safety, pharmacokinetics, & preliminary clinical activity of BT8009 in patients with Nectin-4 expressing advanced malignancies
Presenter: Meredith Mckean
Session: E-Poster Display
Resources:
Abstract
600TiP - A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701)
Presenter: Stefan Symeonides
Session: E-Poster Display
Resources:
Abstract
601TiP - First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours
Presenter: Hans Gelderblom
Session: E-Poster Display
Resources:
Abstract
602TiP - A first-in-human study of NOV1601 (CHC2014), small-molecule inhibitor of TRK family proteins, in adult patients with solid organ malignancies
Presenter: Tak Yun
Session: E-Poster Display
Resources:
Abstract
603TiP - Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations
Presenter: Martin Schuler
Session: E-Poster Display
Resources:
Abstract
604TiP - ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer
Presenter: Serge Leyvraz
Session: E-Poster Display
Resources:
Abstract
605TiP - Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump
Presenter: Morten Ladekarl
Session: E-Poster Display
Resources:
Abstract